GLP1R and diabetes mellitus: Additionally, GLP-1 RAs have demonstrated cardiovascular safety profile in individuals with diabetes (Marso et al., 2016; Husain et al., 2019; Kristensen et al., 2019; Bucheit et al., 2020; Ghosh-Swaby et al., 2020; Ma et al., 2021).